The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...
Safe handling of HPAPIs requires determining exposure potential and selecting appro-priate containment strategies. For drug manufacturers, patient safety is of the utmost concern, and efforts to ...
Cell and gene therapies (CGTs) typically target genetic diseases or diseases with very high unmet needs and limited existing therapeutic options. Therefore, quickly getting these life-altering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results